Stockscreener 앱 받기
327.95
1.35%
4.36
시간 외 거래:
327.95
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
West Pharmaceutical stock under pressure after weekly high as technicals suggest range trading ahead - Traders Union
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services Inc (WST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
West Pharmaceutical stock slips to weekly low amid conflicting momentum signals - Traders Union
Why West Pharmaceutical’s NovaPure plungers quietly matter for injectable drugs - AD HOC NEWS
West Pharmaceutical Services Inc (WST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc (WST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aluminum Crimp Vial Seals Market Forecast to 2035: Growth Accelerates on Biologic Drug Surge and RTU Adoption - IndexBox
Reasons to Retain Baxter International Stock in Your Portfolio for Now - TradingView
West pharmaceutical services strengthens support for china’s biologics ecosystem with integrated prefillable syringe system launch at CPHI China 2026 - The Sun Malaysia
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 - Bluefield Daily Telegraph
West Pharmaceutical Services Inc (WST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
New release highlights: Westar Select Ready Pack vials target small-batch biologics - AD HOC NEWS
New price band, same precision: West’s Stelmi Ready Pack seeks broader biologics use - AD HOC NEWS
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum - Yahoo Finance
Is West Pharmaceutical Stock Outperforming the S&P 500? - Barchart
West Pharmaceutical Stock (US9523901012): Quiet trading day keeps valuation in focus - AD HOC NEWS
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
West Pharmaceutical Services (WST) Is an Injectable-Drug Infrastructure Story, Not Just a Packaging Supplier - AlphaStreet
Is Wall Street bullish or bearish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Stock (US9553061055): Valuation Metrics Under the Microscope on a Quiet Friday - AD HOC NEWS
West Pharmaceutical Stock (US9523901012): Valuation Metrics Under the Microscope - AD HOC NEWS
West Pharma’s GLP-1 Tailwinds Come With A Cybersecurity Footnote - Finimize
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards - Devdiscourse
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - TradingView
West Pharmaceutical Names Thermo Fisher Executive as CEO - MyChesCo
AMN Expands Language Services Portfolio With Jaide Health Deal - TradingView
Motley Fool Wealth Management LLC Reduces Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharma raised to overweight at Barclays on fundamentals - MSN
West Pharmaceutical Services stock hits 52-week high at 331.43 USD - Investing.com Nigeria
West Pharmaceutical Services Inc (WST) Shares Surge 4.7% -- What GF Score of 96 Tells Investors - GuruFocus
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 - Moomoo
Barclays Upgrades West Pharmaceutical Services(WST.US) to Buy Rating, Raises Target Price to $400 - Moomoo
West Pharmaceutical (WST) Boosted to Overweight with Target Rais - GuruFocus
West Pharmaceutical Services appoints Michel Lagarde as next president, CEO - Pennsylvania Business Report -
West Pharmaceutical Services (NYSE:WST) Reaches New 12-Month HighStill a Buy? - MarketBeat
West Pharma stock upgraded at Barclays (WST:NYSE) - Seeking Alpha
Barclays upgrades West Pharmaceutical stock rating on GLP-1 outlook By Investing.com - Investing.com Canada
ING Groep NV Sells 17,581 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth - Insider Monkey
Why Is West Pharmaceutical Drawing Attention Amid Injectable Drug Expansion? - Kalkine Media
Los Angeles Capital Management LLC Has $11.95 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Stock Analysis: A 12% Upside Potential Amid Robust Revenue Growth - DirectorsTalk Interviews
Wolfe Research Initiates Coverage on West Pharmaceutical Services with Outperform RatingStrong Earnings Momentum - newsline.com
Wolfe Research Initiates Coverage on West Pharmaceutical Services (WST) With Outperform RatingGuidance Revision Trend - newsline.com
1.26%
1.32%
자본화:
|
볼륨(24시간):